Dr. Law is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2312 Whitehorse Mercerville Rd
Suite 105
Trenton, NJ 08619Phone+1 608-586-7400Fax+1 609-586-7656
Summary
- Board Certified Pulmonologist with a track record of translational research on alpha1 antitrypsin deficiency, COPD, and interstitial lung disease. My skill set includes Interventional Pulmonology and EBUS
Education & Training
- NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
- Boston University Medical CenterResidency, Internal Medicine, 1987 - 1990
- New York University School of MedicineClass of 1987
- Colgate UniversityBA, Biology, Magna Cum Laude, Phi Beta Kappa, 1979 - 1983
- Boston City HospitalInternship, Internal Medicine
Certifications & Licensure
- NJ State Medical License 1995 - 2025
- NY State Medical License 1991 - 1997
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012
Publications & Presentations
PubMed
- 33 citationsAcyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agentsKaren L Lobb, Philip A Hipskind, James A Aikins, Enrique Alvarez, Yiu-Yin Cheung
Journal of Medicinal Chemistry. 2004-09-23 - 51 citationsTricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)Bryan H. Norman, Joseph Michael Gruber, Sean P. Hollinshead, Joseph W. Wilson, James J. Starling
Bioorganic & Medicinal Chemistry Letters. 2002-03-25 - 35 citationsCyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).Bryan H. Norman, Peter Ambrose Lander, Joseph Michael Gruber, Julian Stanley Kroin, Jeffrey Daniel Cohen
Bioorganic & Medicinal Chemistry Letters. 2005-12-15
Press Mentions
- RWJUH-Hamilton, RWJBarnabus Health Medical Group Welcome Pulmonologist Kevin Law, MDJanuary 4th, 2021
- Stony Brook Council Honors University Pandemic LeadershipFebruary 23rd, 2021
- LI's COVID-19 Infection Rate Rises, and College Students May Be a FactorSeptember 5th, 2020
- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: